Summary
Through a large nationwide, multicenter, prospective, randomized and preferential clinical trial, the American Urological Association plans to evaluate the efficacy of watchful waiting, alpha-blockade, balloon dilation, and transurethral prostatectomy (TURP) in the treatment of benign prostatic hyperplasia. The study, to be conducted at 20 major urological centers in the United States, will primarily address the issue of long-term mortality after TURP and for the first time in any large clinical trial, will evaluate the effect of these management strategies on the patient's quality of life. Completion of the study should provide valuable information, now lacking in the urological literature, concerning the treatment of the most common urological disease of the aging male.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abrams PH, Griffiths DJ (1979) The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51:129–134
Ball AJ, Feneley RC, Abrams PH (1981) The natural history of untreated “prostatism”. Br J Urol 53:613–616
Barnes RW, Marsh C (1983) Progress of obstruction and symptoms. In: Hinman F, Boyarsky S (eds) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 711–713
Barry MJ (1990) Medical outcome research and benign prostatic hyperplasia. Prostate [Suppl] 3:61–74
Barry MJ, Mulley AG, Fowler FJ (1988) Watchful waiting versus immediate transurethral resection for symptomatic prostatism. JAMA 259:3010–3017
Birkhoff JD, Weiderhorn AR, Hamilton ML (1976) Natural history of benign prostatic hypertrophy in acute urinary retention. Urology 7:48–52
Boyarsky S, Jones G, Paulson DF (1977) A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourinary Surg 68:29–32
Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoid residual urine determination and evaluation of prostatism. Urology 20:602–604
Chassin MR, Brook HR, Park RE (1986) Variations in the use of medical and surgical services by the Medicare population. N Engl J Med 314:285–290
Fowler FJ, Wennberg JE, Timothy RP (1988) Symptom status and quality of life following prostatectomy. JAMA 259:3018–3022
Gilpin SA, Gosling JA, Barnard RJ (1985) Morphological and morphometric studies of human obstructed trabeculated urinary bladder. Br J Urol 57:525–529
Graverson PH, Gasser TC, Wasson JH (1989) Controversies about indications for transurethral resection of the prostate. J Urol 141:475–481
Hedlund H, Anderson KE, Ek A (1986) Effects of prazosin in patients with benign prostatic obstruction. J Urol 130:275–278
Holtgrewe HL, Mebust WK, Dowd JB (1989) Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 141:248–253
Kirby RS, Coppinger SWC, Corcoran MO (1987) Prazosin in the treatment of prostatic obstruction — a placebo controlled study. Br J Urol 60:136–142
Madsen PO, Iversen P (1983) A point system for selecting operative candidates. In: Hinman F, Boyarsky S (eds) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 763–765
Malenka DJ, Roos N, Fisher ES (1990) Further study of the mortality following transurethral prostatectomy: a chart based analysis. J Urol 144:224–228
Mebust WK, Holtgrewe HL, Cockett ATK (1989) Transurethral prostatectomy, immediate and postoperative complications. A cooperative study of 13 participating institutions, an evaluation of 3885 patients. J Urol 141:243–247
Omnibus Budget Reconciliation Act (P.L. 101-239) (1989) US Government Printing Office, Washington, DC
Roos NP, Wennberg JE (1989) Mortality and reoperations after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320:1120–1127
Speakman MJ, Broding AF, Gilpin CJ (1987) Bladder outflow obstruction — a cause of denervation supersensitivity. J Urol 138:1461–1466
Wennberg JE (1987) The paradox of appropriate care. JAMA 258:2568–2569
Wennberg JE (1990) Medical innovation at the crossroads, vol I. Modern methods of clinical investigation. National Academy Press, Washington, DC (in press)
Wennberg JE, Bunker JP, Barnes B (1980) The need for assessing the outcome of common medical practice. Annu Rev Publish Health 1:277–295
Wennberg JE, Barnes BA, Zubkoff M (1982) Professional uncertainty in the problem of supplier — induced demand. Soc Sci Med 16:811–824
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holtgrewe, H.L. The treatment of benign prostatic hyperplasia: a prospective, randomized clinical trial to be conducted by the American Urological Association. World J Urol 8, 218–223 (1990). https://doi.org/10.1007/BF01580024
Issue Date:
DOI: https://doi.org/10.1007/BF01580024